Home › Funds › First Turn Management, LLC › MIRM

First Turn Management, LLC position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

First Turn Management, LLC reported holding 218,051 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$25.5M, representing 2.73% of its reported portfolio and ranking #18 among its reported holdings. First Turn Management, LLC has disclosed MIRM holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)218.05K sh
Reported value held$25.53M
Portfolio Weight2.73%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How First Turn Management, LLC's MIRM position evolved

First Turn Management, LLC first disclosed a stake in MIRM in Q4 2023 at 836,302 shares (US$24.7M). The position peaked in Q3 2025 at 570,569 shares, worth US$41.8M. Across 11 filings, First Turn Management, LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 218,051 shares valued at US$25.5M — a reduction of -182,413 shares quarter over quarter.. Notable position changes include a 27% trim in Q2 2024 (shares rose 14% over the following quarter), a 46% trim in Q2 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 836.30K $24.69M New
Q1 2024 958.65K $24.08M Add
Q2 2024 703.40K $24.05M Reduce
Q3 2024 647.61K $25.26M Reduce
Q4 2024 506.91K $20.96M Reduce
Q1 2025 503.01K $22.66M Reduce
Q2 2025 527.54K $26.85M Add
Q3 2025 570.57K $41.83M Add
Q4 2025 481.56K $38.04M Reduce
Q1 2026 400.46K $36.99M Reduce
Q2 2026 218.05K $25.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 62 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has First Turn Management, LLC held MIRM?

First Turn Management, LLC has disclosed MIRM holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is First Turn Management, LLC's current position in MIRM?

As of Q2 2026, First Turn Management, LLC holds 218.05K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $25.53M, representing 2.73% of its reported portfolio and ranking #18.

Has First Turn Management, LLC been buying or selling MIRM?

In the latest 13F filing (Q2 2026), First Turn Management, LLC reduced its position in MIRM. The position peaked in Q3 2025 at 570.57K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.